Baseline procalcitonin as a predictor of bacterial infection and clinical outcomes in COVID-19: A case-control study

PURPOSE: Coronavirus disease-2019 (COVID-19) is associated with a wide spectrum of clinical symptoms including acute respiratory failure. Biomarkers that can predict outcomes in patients with COVID-19 can assist with patient management. The aim of this study is to evaluate whether procalcitonin (PCT...

Descripción completa

Detalles Bibliográficos
Autores principales: Atallah, Natalie J., Warren, Hailey M., Roberts, Matthew B., Elshaboury, Ramy H., Bidell, Monique R., Gandhi, Ronak G., Adamsick, Meagan, Ibrahim, Maryam K., Sood, Rupali, Bou Zein Eddine, Savo, Cobler-Lichter, Matthew J., Alexander, Natalie J., Timmer, Kyle D., Atallah, Christine J., Viens, Adam L., Panossian, Vahe S., Scherer, Allison K., Proctor, Teddie, Smartt, Sherrie, Letourneau, Alyssa R., Paras, Molly L., Johannes, Sascha, Wiemer, Jan, Mansour, Michael K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8758006/
https://www.ncbi.nlm.nih.gov/pubmed/35025929
http://dx.doi.org/10.1371/journal.pone.0262342

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8758006/
https://www.ncbi.nlm.nih.gov/pubmed/35025929
http://dx.doi.org/10.1371/journal.pone.0262342

Ejemplares similares